IQVIA’s white paper highlights how advanced analytics, AI, and GenAI are transforming clinical trial planning and execution. By moving from descriptive to predictive and prescriptive analytics, sponsors can reduce risks and improve confidence. Key innovations include Healthcare-grade AI® for predicting drug response and identifying viable targets, protocol digitization to cut trial complexity, and AI-driven enrollment modeling for faster, more accurate recruitment. Regulatory intelligence tools also accelerate site startup by interpreting local requirements. Looking ahead, agentic AI will automate multi-step decisions, driving greater precision, speed, and scalability in trial delivery.

Join for free to read